It also inhibits 12/15-lipoxygenases and GSK3β activity, reduces BACE1 and Aβ production, prevents tau phosphorylation, and restores spine density and LTP in AD model [165, 166]. The gene discussed is MAPT; the disease is Alzheimer disease.